Center for Scientific Review

Center for Scientific Review
Name	Center for Scientific Review
Type	Federal agency
Location	Bethesda, Maryland
Founded	1946
Parent organization	National Institutes of Health

Center for Scientific Review The Center for Scientific Review manages peer review for biomedical and behavioral research applications submitted to the National Institutes of Health, coordinating reviews across programs tied to the National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute on Aging, and National Institute of Child Health and Human Development. It interfaces with offices including the Office of the Director, NIH, the National Institute of Neurological Disorders and Stroke, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Heart, Lung, and Blood Institute to align evaluation standards, study section assignments, and review timelines. The center's processes affect grant decisions that impact investigators at institutions such as Harvard University, Johns Hopkins University, Stanford University, University of California, San Francisco, and Massachusetts Institute of Technology.

History

Established after World War II, the center traces roots to reorganizations around the National Institutes of Health in the mid-20th century, paralleling shifts seen in entities like the National Research Council, the Advisory Committee to the Director, and reforms following reports from the Institute of Medicine. Its evolution intersected with policy decisions influenced by the Office of Management and Budget, congressional appropriations debates in the United States Congress, and scientific workforce crises echoed in panels convened by the National Academy of Sciences and the Blue Ribbon Commission. Major restructuring episodes referenced practices from the Peer Review Reform Taskforce, responses to high-profile controversies involving institutions such as Oxford University, University of Pennsylvania, and report-driven changes reminiscent of recommendations from the Berg Commission and the Koshland Commission.

Mission and role

The center's mission is to provide fair, expert review for grant applications to the National Institutes of Health, to support award recommendations to institutes like the National Cancer Institute, National Institute on Drug Abuse, and National Institute of Environmental Health Sciences, and to uphold standards promoted by bodies such as the National Academies of Sciences, Engineering, and Medicine, the World Health Organization, and the Food and Drug Administration. It serves as a bridge between programmatic officers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, policy offices such as the Office of Research on Women’s Health, and stakeholders including academic centers like Yale University, Columbia University, University of Chicago, and University of California, San Diego. The role also overlaps with initiatives tied to the Human Genome Project, pandemic responses coordinated with the Centers for Disease Control and Prevention, and translational priorities promoted by the National Center for Advancing Translational Sciences.

Organization and leadership

Organizationally, the center reports to the Office of the Director, NIH and coordinates with institute directors at the National Institute of Neurological Disorders and Stroke, National Institute on Alcohol Abuse and Alcoholism, and National Institute on Aging. Leadership has included directors and deputy directors drawn from academic and research institutions such as University of Pennsylvania, Duke University, Vanderbilt University, and University of Michigan, and works with advisory groups akin to the Advisory Committee to the Director and panels from the National Academy of Medicine. Administrative functions align with human resources practices at federal agencies like the Department of Health and Human Services and budgetary oversight from the Office of Management and Budget.

Peer review process

The peer review process engages external reviewers appointed from institutions such as Harvard University, Stanford University, University of California, Berkeley, Princeton University, and Massachusetts Institute of Technology organized into study sections modeled after review practices at the National Science Foundation and committees exemplified by the Howard Hughes Medical Institute. Review cycles follow timelines influenced by policies from the National Institutes of Health and metrics used by the National Academies of Sciences, Engineering, and Medicine, with criteria paralleling standards in grant competitions overseen by the European Research Council and peer-review reforms advocated by groups like the Wellcome Trust. Review panels evaluate impact, significance, innovation, and approach referencing methodological standards cited by journals such as Nature, Science, The Lancet, Cell, and Proceedings of the National Academy of Sciences.

Study sections and scientific review groups

Study sections and scientific review groups are organized by topic areas that mirror departments at universities such as Columbia University, University of California, San Francisco, Yale University, Johns Hopkins University, and Duke University. They cover domains overlapping centers like the National Cancer Institute, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and subject-focused consortia including the Alzheimer’s Disease Research Centers and initiatives similar to the Human Connectome Project and the BRAIN Initiative. Membership includes investigators with affiliations at institutions such as UCLA, University of Texas Southwestern Medical Center, Scripps Research Institute, Mount Sinai Health System, and Cold Spring Harbor Laboratory.

Funding and resources

Funding for review operations is allocated through appropriations to the National Institutes of Health from the United States Congress and is managed in coordination with offices like the Office of Management and Budget and the Department of Health and Human Services. Resources support staff who liaise with program officers at institutes including the National Institute of Diabetes and Digestive and Kidney Diseases, the National Heart, Lung, and Blood Institute, and the National Institute of General Medical Sciences, and inform allocation decisions that affect awardees at universities such as Washington University in St. Louis, University of Pennsylvania, Cornell University, and Brown University. The center also interacts with funders and partners like the Bill & Melinda Gates Foundation, the Howard Hughes Medical Institute, and the Wellcome Trust on matters of shared interest in peer review standards.

Criticisms and reforms

Criticisms have targeted transparency, reviewer workload, and potential bias, drawing attention from commentators at outlets like The New York Times, The Washington Post, and Scientific American and prompting reviews analogous to recommendations from the National Academies of Sciences, Engineering, and Medicine and advocacy groups including the American Association for the Advancement of Science and the Association of American Universities. Reforms debated include modifications to review criteria inspired by the DORA Declaration, adjustments to conflict-of-interest policies similar to reforms at the National Science Foundation, and pilot changes echoing initiatives by the European Research Council and funders such as the Wellcome Trust.